Lola Felice Lin - 27 Feb 2026 Form 4 Insider Report for GE Vernova Inc. (GEV)

Role
Chief Legal Officer
Signature
/s/ Richmond Glasgow, VP, Chief Corporate Counsel & Deputy Secretary, as attorney-in-fact
Issuer symbol
GEV
Transactions as of
27 Feb 2026
Net transactions value
$0
Form type
4
Filing time
03 Mar 2026, 19:15:12 UTC
Previous filing
24 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LIN LOLA FELICE Chief Legal Officer 58 CHARLES STREET, CAMBRIDGE /s/ Richmond Glasgow, VP, Chief Corporate Counsel & Deputy Secretary, as attorney-in-fact 03 Mar 2026 0001870422

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEV Restricted Stock Units Award $0 +1,211 $0.000000 1,211 27 Feb 2026 Common stock, par value $0.01 per share 1,211 Direct F1, F2
transaction GEV Restricted Stock Units Award $0 +6,987 $0.000000 6,987 27 Feb 2026 Common stock, par value $0.01 per share 6,987 Direct F1, F3
transaction GEV Employee Stock Option (right to buy) Award $0 +1,648 $0.000000 1,648 27 Feb 2026 Common stock, par value $0.01 per share 1,648 $873.60 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, at settlement, one share of GE Vernova Inc. ("GE Vernova") common stock.
F2 Represents an award of restricted stock units with respect to GE Vernova common stock that will vest in three installments of 33% on March 1, 2027, 33% on March 1, 2028 and 34% on March 1, 2029.
F3 Represents an award of restricted stock units with respect to GE Vernova common stock that will vest 50% on March 1, 2027 and 50% on March 1, 2028.
F4 Represents an award of an employee stock option with respect to GE Vernova common stock, of which 33% will become exercisable on March 1, 2027, 33% will become exercisable on March 1, 2028 and 34% will become exercisable on March 1, 2029.